Please check your internet connection and try again.
# Megacv Duo (Amoxicillin/Clavulanate Potassium)
## Overview
Megacv Duo is a combination antibiotic consisting of amoxicillin (a beta-lactam) and clavulanate potassium (a beta-lactamase inhibitor). The clavulanate component expands the spectrum of activity to include beta-lactamase-producing organisms that are typically resistant to amoxicillin alone.
## Primary Indications
* Community-acquired pneumonia
* Acute bacterial sinusitis
* Acute otitis media
* Skin and skin-structure infections
* Urinary tract infections
* Lower respiratory tract infections
## Adult Dosing
* **Standard dosing:** 500 mg/125 mg orally every 8 hours or 875 mg/125 mg orally every 12 hours.
* **Severe infections:** 875 mg/125 mg every 8 hours (using extended-release formulations or tablets).
* **Maximum:** Do not exceed 2000 mg of amoxicillin component per day with the 875 mg/125 mg tablet formulation unless using specific high-dose extended-release protocols.
## Pediatric Dosing
* **Dosing is weight-based:** Typically 20–45 mg/kg/day of the amoxicillin component in divided doses every 8–12 hours, depending on the severity of the infection and local resistance patterns.
* **Acute Otitis Media:** Often dosed at 90 mg/kg/day (amoxicillin component) in two divided doses to overcome resistant *S. pneumoniae*.
* **Constraint:** The ratio of amoxicillin to clavulanate is critical; use the 7:1 or 14:1 formulations for high-dose regimens to avoid excessive clavulanate intake, which can cause diarrhea.
## Dose Adjustments
* **Renal Impairment:** Reduce dosage or increase dosing interval if CrCl < 30 mL/min.
* **Hemodialysis:** Administer a single dose after dialysis.
* *Note: Consult local clinical guidelines or renal dosing references for CrCl-specific titration.*
## Contraindications
* History of serious hypersensitivity reactions (e.g., anaphylaxis, Stevens-Johnson syndrome) to penicillins or any component of the formulation.
* History of cholestatic jaundice or hepatic dysfunction associated with past use of amoxicillin/clavulanate.
## Adverse Effects
* **Gastrointestinal:** Diarrhea (very common), nausea, vomiting, abdominal pain.
* **Dermatologic:** Rash (monitor for IgE-mediated reactions).
* **Hepatic:** Potential for elevated liver transaminases and rare cholestatic jaundice.
* **General:** Candidiasis (thrush/vaginitis) due to bacterial flora disruption.
## Key Drug Interactions
* **Warfarin:** May increase INR/bleeding risk; monitor INR closely.
* **Methotrexate:** May decrease clearance and increase toxicity.
* **Oral Contraceptives:** Efficacy may be reduced; suggest backup contraception during therapy.
* **Probenecid:** Increases amoxicillin serum concentrations; often avoided.
## Monitoring
* Monitor for signs of anaphylaxis during the first dose.
* Assess for resolution of infection symptoms.
* Monitor renal function in patients with pre-existing impairment.
* Monitor LFTs if therapy duration exceeds 14 days.
## Clinical Pearls
* **Administration:** Take with a meal or snack to minimize gastrointestinal upset.
* **Clavulanate Ratio:** Use specific pediatric suspensions (e.g., 600 mg/5 mL) for high-dose regimens to ensure the correct amoxicillin:clavulanate ratio.
* **Storage:** Most reconstituted oral suspensions require refrigeration and must be discarded after 10 days.
* **Antibiotic Stewardship:** Avoid using for viral infections; ensure dose is appropriate for the site of infection and suspected pathogen susceptibility.
***
**Educational Disclaimer:** This information is for educational purposes only. Clinical practice guidelines and local resistance patterns change frequently. Always verify current prescribing information, patient-specific allergies, and renal function via official resources (e.g., Lexicomp, UpToDate) before prescribing or administering medication.
